New England Society of Allergy
 

2021 Fall Conference

Register Now button

 

 

Conference Agenda/Videos

 
 
Hereditary Alpha Tryptasemia and Mast Cell Activation Syndrome

Josh Milner, MD
Professor of Pediatrics and the Institute for Genomic Medicine
Director, Division of Allergy, Immunology and Rheumatology
Columbia University Medical Center
New York-Presbyterian Morgan Stanley Children's Hospital
 

Primary atopic disorders and immunologic basis for atopic disease

Josh Milner, MD
Professor of Pediatrics and the Institute for Genomic Medicine
Director, Division of Allergy, Immunology and Rheumatology
Columbia University Medical Center
New York-Presbyterian Morgan Stanley Children's Hospital
 

Pharmacogenomics of Asthma: Past, Present & Future

Alberta Wang, MD, MS
Instructor, Harvard Medical School
Division of Allergy and Clinical Immunology
Brigham and Women's Hospital
 

The P’s of Oral immunotherapy- Pitfalls and Pearls

Hugh Windom, MD
Windom Allergy, Asthma and Sinus
Food Allergy Center of Florida

Sponsors



thermofisherlogo

 

From stinging insects to alpha-Gal, watch new allergen components available to you as well as how allergen component diagnostic testing may aid in allergy patient management and diagnosis. 

This presentation will cover:

  • The advantages and limitations of allergen component resolved diagnostics 
  • A breakdown of allergen components in milk, egg, peanut, tree nuts, red meat, pets, and stinging insect allergies
  • How to interpret and use allergen component test results to optimize patient management

Watch Video Now:
New Advances in Component Resolved Diagnosis
 



astrazeneca1


 

 


Takeda_logo

It’s Takeda’s privilege to be joining you virtually this week for the New England Society of Allergy Meeting.
Takeda is a biopharmaceutical leader founded in Japan 240 years ago and has been serving the Primary Immunodeficiency and Hereditary Angioedema community for decades.
Please click here to visit our virtual experience to learn about our products, and support and resources for people living with Primary Immunodeficiency and Hereditary Angioedema.

For questions regarding our commercially approved HAE products and support and resources, please contact:

Dana Cappello
Regional Business Manager

Dana.capello@takeda.com
617-620-0035

For questions regarding our commercially approved PI products and support and resources, please contact:

Mary Iannella
Territory Business Manager

Mary.iannella@takeda.com
508-740-9645
 


 

blueprintmedical_logo

Welcome to AYVAKIT​

Explore information about this once-daily treatment for adults with advanced systemic mastocytosis (Advanced SM).
www.ayvakit.com